Skip to main content
Figure 3 | Malaria Journal

Figure 3

From: A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria

Figure 3

Survival analysis showing parasite clearance per individual in the respective groups. SCD-AA = artesunate-amodiaquine-treated sickle cell disease subjects with acute malaria; SCD-AL = artemether-lumefantrine-treated sickle cell disease subjects with acute malaria; non-SCD = non sickle cell disease (haemoglobin genotype AA) subjects with acute malaria.

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us